Orthofix Medical (OFIX) EBITDA Margin (2010 - 2026)

Orthofix Medical (OFIX) posted EBITDA Margin of 9.01% for Q1 2026, down 39.25% on a QoQ basis from 14.84% in Q4 2025, and down 105.0% year-over-year from 180.29% in Q1 2025.

Orthofix Medical (OFIX) EBITDA Margin (2010 - 2026) Analysis & Trends

Orthofix Medical's EBITDA Margin history runs 17 years deep, the most recent figure standing at 9.01% for Q1 2026.

  • Quarterly EBITDA Margin fell 105.0% year-over-year to 9.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.6% (down 3.0% YoY) and the FY2025 annual result came in at 14.45%, up 44.0% from the prior year.
  • EBITDA Margin was 9.01% for Q1 2026 at Orthofix Medical, down from 14.84% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 28.78% in Q4 2022 and bottomed at 1.97% in Q1 2023.
  • A 5-year average of 12.8% and a median of 12.54% in 2023 frame the typical range for EBITDA Margin.
  • Peak annual rise in EBITDA Margin reached 801 bps in 2022, while the deepest fall reached 3053 bps in 2022.
  • Orthofix Medical's EBITDA Margin stood at 28.78% in 2022, then plunged by 44 bps to 16.14% in 2023, then decreased by 13 bps to 14.03% in 2024, then grew by 6 bps to 14.84% in 2025, then tumbled by 39 bps to 9.01% in 2026.
  • Business Quant data shows OFIX's EBITDA Margin at 9.01% in Q1 2026, 14.84% in Q4 2025, and 15.82% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 181.19 Bn 173.90 Bn 6.27 Bn 12.05%
2 Stryker 128.53 Bn 125.65 Bn 3.81 Bn 15.55%
3 Medtronic 107.77 Bn 98.55 Bn 6.41 Bn 19.10%
4 Boston Scientific 67.72 Bn 66.27 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 48.21 Bn 44.54 Bn 1.29 Bn 28.97%
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 21.42%
7 GE HealthCare Technologies 28.33 Bn 26.05 Bn 1.98 Bn 10.04%
8 Smith & Nephew 26.76 Bn 26.18 Bn - -
9 Koninklijke Philips 25.27 Bn 22.15 Bn 2.07 Bn 6.17%
10 Orthofix Medical 457.89 Mn 337.02 Mn 139.55 Mn 9.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 9.01%
Dec 31, 2025 14.84%
Sep 30, 2025 15.82%
Jun 30, 2025 14.24%
Mar 31, 2025 10.06%
Dec 31, 2024 14.03%
Sep 30, 2024 15.29%
Jun 30, 2024 15.03%
Mar 31, 2024 9.75%
Dec 31, 2023 16.14%
Sep 30, 2023 12.54%
Jun 30, 2023 11.29%
Mar 31, 2023 1.97%
Dec 31, 2022 28.78%
Sep 30, 2022 12.50%
Jun 30, 2022 9.67%
Mar 31, 2022 6.68%
Dec 31, 2021 59.31%
Sep 30, 2021 4.49%
Jun 30, 2021 10.53%